Driving CAR-T therapy safety and sustainability for the road ahead
Q&A with Abby McDonald, PhD, Solutions Development Supervisor
An opportunity to impact the future of medicine
As told by Leah, Be The Match BioTherapies® allogeneic donor
The challenge of multiple audits and redundant training
A case study from UCLA Health
Industry stakeholders propose unified CAR T toxicity grading scale
CIBMTR Cellular Therapy Registry recommended to meet outcomes data reporting requirements
